한글목차

HPV 검사 및 Pap 테스트 동향 및 예측

세계의 HPV 검사 및 Pap 테스트 시장은 2024년부터 2030년까지의 복합 연간 성장률(CAGR) 6.5%를 나타낼 전망이며 2030년까지 추정 75억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 HPV 증례 증가와 그에 따른 자궁 경부암 증가, 자궁 경부암 검진의 대처에 대한 의식의 높아짐, 자궁 경부암 연구 개발 프로젝트에 대한 자금 조달 증가입니다. 세계의 HPV 검사 및 Pap 테스트 시장의 미래는 병원, 클리닉 및 검사 시설 시장에서의 기회에 의해 유망시되고 있습니다.

HPV 검사 및 Pap 테스트 시장 인사이트

Lucintel은 시장 진출기업의 투자가 증가하고 있으며 질암에 비해 자궁 경부암의 발생이 많기 때문에 자궁 경부암 검진은 예측 기간 중에도 계속 큰 부문라고 예측했습니다.

북미는 자궁경부암 조기 발견에 대한 높은 의식, 확립된 검진 권장, 뛰어난 헬스케어 상환환경이 확대를 촉진하고 있기 때문에 예측기간 중에도 최대지역으로 지속될 것입니다.

FAQ

Q1. 시장 규모는?

A1. HPV 검사 및 Pap 테스트 세계 시장은 2030년까지 예상 75억 달러에 이를 것으로 예상됩니다.

Q2. 시장의 성장 예측은?

A2. 세계의 HPV 검사 및 Pap 테스트 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 6.5%로 성장할 것으로 예측됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은?

A3.이 시장의 주요 촉진요인은 HPV 증례 증가와 그에 따른 자궁 경부암 증가, 자궁 경부암 검진의 대처에 대한 의식 증가, 자궁 경부암 연구 개발 프로젝트에 대한 자금 조달 증가입니다.

Q4. 시장의 주요 부문은?

A4. 세계의 HPV 검사 및 Pap 테스트 시장의 미래는 병원, 클리닉 및 검사 시설 시장에서의 기회에 의해 유망할 것으로 보입니다.

Q5. 시장의 주요 기업은?

A5. HPV 검사 및 Pap 테스트 주요 기업은 다음과 같습니다.

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

Q6. 앞으로 가장 큰 시장 부문은?

A6. Lucintel은 자궁 경부암 검진은 시장 진출기업의 산업에 대한 투자가 증가하고 있음, 자궁 경부암은 질암에 비해 발생률이 높기 때문에 예측 기간 중 큰 부문이 계속 될 것으로 예측됩니다.

Q7. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은?

A7. 북미는 자궁경부암 조기발견에 대한 높은 인지도, 확립된 검진추천, 뛰어난 헬스케어 상환환경이 확대를 촉진하고 있기 때문에 예측기간 동안에도 최대의 지역으로 남아 있습니다.

Q8. 보고서의 커스터마이즈는 가능?

A8. 그렇습니다, Lucintel는 추가 비용 없이 10% 주문을 받아서 만듭니다.

목차

제1장 주요 요약

제2장 세계의 HPV 검사와 Pap 테스트 검사 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018년-2023년)과 예측(2024년-2030년)
• 세계의 HPV 검사와 Pap 테스트 시장 동향(2018년-2023년)과 예측(2024년-2030년)
• 검사 유형별 세계의 HPV 검사와 Pap 테스트 검사 시장
  • Pap 테스트
  • HPV 검사
• 제품별 세계의 HPV 검사 및 Pap 테스트 검사 시장
  • 기기
  • 소모품
  • 서비스
• 용도별 세계의 HPV 검사 및 Pap 테스트 검사 시장
  • 자궁 경부암 검진
  • 질암 검진
• 최종 용도별 세계의 HPV 검사와 Pap 테스트 검사 시장
  • 병원 및 진료소
  • 연구실
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018년-2023년)

• 지역별 세계의 HPV 검사 및 Pap 테스트 검사 시장
• 북미의 HPV 검사 및 Pap 테스트 시장
• 유럽의 HPV 검사 및 Pap 테스트 검사 시장
• 아시아태평양의 HPV 검사 및 Pap 테스트 검사 시장
• 기타 지역의 HPV 검사와 Pap 테스트 검사 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 검사 유형별 세계의 HPV 검사와 Pap 테스트 검사 시장의 성장 기회
  • 제품별 세계의 HPV 검사와 Pap 테스트 검사 시장의 성장 기회
  • 용도별 세계의 HPV 검사와 Pap 테스트 검사 시장의 성장 기회
  • 최종 용도별 세계의 HPV 검사와 Pap 테스트 검사 시장의 성장 기회
  • 지역별 세계의 HPV 검사와 Pap 테스트 검사 시장의 성장 기회
• 세계의 HPV 검사와 Pap 테스트 검사 시장에서의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 HPV 검사와 Pap 테스트 검사 시장의 능력 확대
  • 세계의 HPV 검사와 Pap 테스트 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 유력 기업의 기업 프로파일

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

영문목차

HPV Testing and Pap Test Trends and Forecast

The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market. The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

A more than 150-page report is developed to help in your business decisions.

HPV Testing and Pap Test by Segment

The study includes a forecast for the global HPV Testing and Pap Test by test type, product, application, end use, and region.

HPV Testing and Pap Test Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Pap Test
• HPV Test

HPV Testing and Pap Test Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

HPV Testing and Pap Test Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cervical Cancer Screening
• Vaginal Cancer Screening

HPV Testing and Pap Test Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Laboratories
• Others

HPV Testing and Pap Test Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of HPV Testing and Pap Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HPV Testing and Pap Test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HPV Testing and Pap Test companies profiled in this report include-

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

HPV Testing and Pap Test Market Insights

Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Features of the Global HPV Testing and Pap Test Market

Market Size Estimates: HPV testing and pap test market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HPV testing and pap test market size by various segments, such as by test type, product, application, end use, and region in terms of value ($B).

Regional Analysis: HPV testing and pap test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test type, product, application, end use, and regions for the HPV Testing and Pap Test market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HPV Testing and Pap Test market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HPV Testing and Pap Test market size?

Answer: The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030.

Q2. What is the growth forecast for HPV Testing and Pap Test market?

Answer: The global HPV Testing and Pap Test market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HPV Testing and Pap Test market?

Answer: The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

Q4. What are the major segments for HPV Testing and Pap Test market?

Answer: The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market.

Q5. Who are the key HPV Testing and Pap Test market companies?

Answer: Some of the key HPV Testing and Pap Test companies are as follows.

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

Q6. Which HPV Testing and Pap Test market segment will be the largest in future?

Answer: Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

Q7. In HPV Testing and Pap Test market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the HPV Testing and Pap Test market by test type (pap test and HPV test), product (instruments, consumables, and services), application (cervical cancer screening and vaginal cancer screening), end use (hospitals & clinics, laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HPV Testing and Pap Test Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global HPV Testing and Pap Test Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global HPV Testing and Pap Test Market by Test Type
  • 3.3.1: Pap Test
  • 3.3.2: HPV Test
• 3.4: Global HPV Testing and Pap Test Market by Product
  • 3.4.1: Instruments
  • 3.4.2: Consumables
  • 3.4.3: Services
• 3.5: Global HPV Testing and Pap Test Market by Application
  • 3.5.1: Cervical Cancer Screening
  • 3.5.2: Vaginal Cancer Screening
• 3.6: Global HPV Testing and Pap Test Market by End Use
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Laboratories
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global HPV Testing and Pap Test Market by Region
• 4.2: North American HPV Testing and Pap Test Market
  • 4.2.1: North American HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.2.2: North American HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.3: European HPV Testing and Pap Test Market
  • 4.3.1: European HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.3.2: European HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.4: APAC HPV Testing and Pap Test Market
  • 4.4.1: APAC HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.4.2: APAC HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.5: ROW HPV Testing and Pap Test Market
  • 4.5.1: ROW HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.5.2: ROW HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global HPV Testing and Pap Test Market by Test Type
  • 6.1.2: Growth Opportunities for the Global HPV Testing and Pap Test Market by Product
  • 6.1.3: Growth Opportunities for the Global HPV Testing and Pap Test Market by Application
  • 6.1.4: Growth Opportunities for the Global HPV Testing and Pap Test Market by End Use
  • 6.1.5: Growth Opportunities for the Global HPV Testing and Pap Test Market by Region
• 6.2: Emerging Trends in the Global HPV Testing and Pap Test Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global HPV Testing and Pap Test Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HPV Testing and Pap Test Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: QIAGEN
• 7.3: BD
• 7.4: Quest Diagnostics
• 7.5: Hologic
• 7.6: F. Hoffmann-La Roche
• 7.7: Femasys
• 7.8: Arbor Vita
• 7.9: NURX
• 7.10: Seegene